Weiss Multi Strategy Advisers LLC Nevro Corp Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $870,600 - $1 Million	-15,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $532,800 - $939,300	15,000 New	15,000 $938,000
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $1.11 Million - $1.89 Million	-25,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $1.27 Million - $1.62 Million	-17,500 Reduced 41.18%	25,000 $2 Million
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $382,029 - $487,134	-5,500 Reduced 11.46%	42,500 $3.68 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $197,820 - $279,930	3,000 Added 6.67%	48,000 $3.31 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $3.64 Million - $4.1 Million	45,000	45,000 $4.09 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.